Oppenheimer & CO Inc Tekla Life Sciences Investors Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Oppenheimer & CO Inc holds 19,598 shares of HQL stock, worth $269,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,598

Previous 24,186 18.97%

Holding current value

$269,668

Previous $342,000 13.74%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$14.26 - $15.78 $65,424 - $72,398	-4,588 Reduced 18.97%	19,598 $295,000
Q2 2024 Aug 07, 2024	BUY	$12.79 - $14.27 $73,823 - $82,366	5,772 Added 31.35%	24,186 $342,000
Q1 2024 May 06, 2024	BUY	$13.38 - $14.33 $10,891 - $11,664	814 Added 4.63%	18,414 $250,000
Q3 2023 Nov 07, 2023	BUY	$12.38 - $13.69 $4,815 - $5,325	389 Added 2.26%	17,600 $219,000
Q2 2023 Aug 02, 2023	BUY	$13.13 - $14.17 $5,068 - $5,469	386 Added 2.29%	17,211 $233,000
Q1 2023 May 10, 2023	BUY	$13.37 - $14.94 $5,361 - $5,990	401 Added 2.44%	16,825 $234,000
Q4 2022 Feb 07, 2023	BUY	$13.55 - $15.23 $298 - $335	22 Added 0.13%	16,424 $233,000
Q3 2022 Nov 14, 2022	BUY	$13.39 - $16.31 $4,780 - $5,822	357 Added 2.22%	16,402 $225,000
Q2 2022 Aug 08, 2022	BUY	$13.11 - $17.02 $5,139 - $6,671	392 Added 2.5%	16,045 $228,000
Q1 2022 May 12, 2022	BUY	$15.35 - $19.29 $5,648 - $7,098	368 Added 2.41%	15,653 $259,000
Q4 2021 Feb 02, 2022	BUY	$18.5 - $21.59 $4,125 - $4,814	223 Added 1.48%	15,285 $295,000
Q3 2021 Nov 12, 2021	BUY	$20.27 - $22.67 $7,925 - $8,863	391 Added 2.67%	15,062 $313,000
Q2 2021 Aug 03, 2021	BUY	$19.14 - $21.44 $5,359 - $6,003	280 Added 1.95%	14,671 $314,000
Q1 2021 May 10, 2021	SELL	$19.31 - $22.07 $2,201 - $2,515	-114 Reduced 0.79%	14,391 $284,000
Q4 2020 Feb 11, 2021	BUY	$16.8 - $20.21 $4,737 - $5,699	282 Added 1.98%	14,505 $286,000
Q3 2020 Nov 13, 2020	SELL	$16.71 - $19.06 $178,446 - $203,541	-10,679 Reduced 42.88%	14,223 $250,000
Q2 2020 Aug 11, 2020	SELL	$14.22 - $18.38 $6,356 - $8,215	-447 Reduced 1.76%	24,902 $447,000
Q1 2020 May 08, 2020	BUY	$12.22 - $17.99 $20,040 - $29,503	1,640 Added 6.92%	25,349 $380,000
Q4 2019 Feb 07, 2020	BUY	$14.63 - $17.84 $3,379 - $4,121	231 Added 0.98%	23,709 $413,000
Q3 2019 Oct 31, 2019	SELL	$15.09 - $17.09 $102,340 - $115,904	-6,782 Reduced 22.41%	23,478 $355,000
Q2 2019 Aug 09, 2019	BUY	$15.54 - $17.47 $10,116 - $11,372	651 Added 2.2%	30,260 $510,000
Q1 2019 Apr 24, 2019	BUY	$15.5 - $17.9 $8,199 - $9,469	529 Added 1.82%	29,609 $508,000
Q4 2018 Jan 29, 2019	BUY	$13.99 - $20.35 $8,645 - $12,576	618 Added 2.17%	29,080 $439,000
Q3 2018 Oct 26, 2018	SELL	$18.89 - $20.49 $22,573 - $24,485	-1,195 Reduced 4.03%	28,462 $582,000
Q2 2018 Aug 10, 2018	BUY	$18.13 - $19.4 $34,392 - $36,801	1,897 Added 6.83%	29,657 $556,000
Q1 2018 May 01, 2018	BUY	$18.92 - $21.52 $6,224 - $7,080	329 Added 1.2%	27,760 $534,000
Q4 2017 Feb 07, 2018	BUY	$18.31 - $22.24 $15,215 - $18,481	831 Added 3.12%	27,431 $538,000
Q3 2017 Nov 09, 2017	BUY	$20.12 - $21.88 $535,192 - $582,008	26,600	26,600 $572,000

Others Institutions Holding HQL

# of Institutions

Shares Held

9.23M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Tekla Life Sciences Investors Transaction History